Recombinant human endostatin in combination with CHOP regimen for peripheral T cell lymphoma
[OncoTargets and Therapy] This research examines the efficacy and safety of recombinant human endostatin in combination with CHOP regimen (ECHOP) for patients with peripheral T cell lymphoma.
